Journal Guide
Publishing in New England Journal of Medicine: Fit, Timeline & Submission Guide
The world's leading clinical journal: where practice-changing research gets published
Should you submit here?
Submit if will physicians change how they treat patients on Monday morning after reading your paper. Be careful if nEJM wants definitive answers.
78.5
Impact Factor (2024)
<5%
Acceptance Rate
21 days median to first decision
Time to First Decision
Submission guide
NEJM Submission Guide
A practical NEJM submission guide for authors deciding whether the manuscript has the clinical consequence, breadth, and package quality NEJM expects.
Journal assessment
Is New England Journal of Medicine a Good Journal? A Practical Fit Verdict
A practical NEJM fit verdict for authors deciding whether their study is truly practice-changing enough for one of medicine's hardest editorial screens.
Desk rejection
How to Avoid Desk Rejection at NEJM
How to avoid desk rejection at NEJM: prove broad clinical consequence, hard endpoints, and study authority strong enough for general medicine.
Comparison guide
NEJM vs Lancet vs JAMA vs BMJ
NEJM vs Lancet vs JAMA vs BMJ compared. Impact factors, acceptance rates, editorial priorities, and a decision framework for clinical researchers.
What NEJM Publishes
NEJM publishes clinical research that directly changes medical practice. They want studies that every physician needs to know about, work that will be discussed at grand rounds worldwide the week it publishes. The bar isn't statistical significance; it's clinical significance.
- Large-scale clinical trials with definitive answers to treatment questions
- Studies that will immediately change clinical practice guidelines
- Research with clear implications for patient care decisions
- Public health findings of urgent importance
- Novel therapeutics with practice-changing efficacy data
Editor Insight
“NEJM exists to change clinical practice. Every paper should answer the question: 'Should I treat patients differently now?' If your study is scientifically interesting but doesn't directly affect patient care, it belongs in a specialty journal.”
What NEJM Editors Look For
Practice-changing clinical impact
Will physicians change how they treat patients on Monday morning after reading your paper? If the answer isn't clearly yes, NEJM probably isn't the right venue.
Hard clinical endpoints
Mortality, major cardiovascular events, disease-free survival. Surrogate endpoints (biomarkers, imaging findings) are less compelling unless clearly tied to outcomes that matter to patients.
Large, well-powered studies
NEJM rarely publishes underpowered pilot studies. If you have promising Phase 2 data, they want the Phase 3. Adequate sample size isn't optional.
Rigorous methodology
Randomization, blinding, intention-to-treat analysis, pre-registration. NEJM has zero tolerance for methodological shortcuts. Your trial design must be bulletproof.
Global relevance
Findings applicable across healthcare systems, not just in well-resourced settings. NEJM has an international readership and values work with broad applicability.
Independence from sponsor interests
Industry-sponsored trials must have clear independence safeguards. Data access, publication rights, and author control must be explicitly addressed.
Why Papers Get Rejected
These patterns appear repeatedly in manuscripts that don't make it past NEJM's editorial review:
Submitting pilot studies as Original Articles
NEJM wants definitive answers. A 50-patient study showing a promising trend belongs in a specialty journal. Come back when you have the full trial.
Focusing on surrogate endpoints
Showing that a drug improves a biomarker is less compelling than showing it prevents heart attacks or extends survival. NEJM prioritizes patient-centered outcomes.
Burying clinical implications
Your abstract should make the practice implications crystal clear. Physicians reading NEJM are busy; they need to know immediately what this means for their patients.
Single-center studies without validation path
Findings from one institution raise generalizability concerns. Multi-center designs or clear plans for external validation strengthen submissions.
Protocol deviations without justification
NEJM scrutinizes adherence to registered protocols. Any deviation needs clear, documented justification. Post-hoc analyses should be labeled as exploratory.
Inadequate safety reporting
thorough adverse event reporting isn't optional. Selective reporting of harms undermines credibility and raises ethical concerns.
Does your manuscript avoid these patterns?
The Free Readiness Scan reads your full manuscript against NEJM's criteria and flags the specific issues most likely to cause rejection.
Insider Tips from NEJM Authors
NEJM wants definitive answers, not promising signals
If your trial is Phase 2 with exciting results, resist the urge to submit to NEJM. Complete the Phase 3 first. NEJM is where you publish the answer, not the question.
The 'Monday morning' test is real
When evaluating your paper, editors ask: will a physician change practice after reading this? If the change is 'consider this option' rather than 'do this now,' impact is diluted.
NEJM has the fastest editorial process among top journals
They understand that clinical findings can be time-sensitive. If you have urgent results (pandemic, safety signal), communicate this clearly.
Editorials and perspectives are commissioned
You can't submit an opinion piece. These are invited by editors. Focus on Original Articles unless you've been contacted.
Pre-registration is scrutinized intensely
Your submitted paper must align with your registered protocol and outcomes. Any changes need explanation. Fishing expeditions are detected.
Patient-reported outcomes increasingly valued
Quality of life, functional status, patient experience: these complement hard endpoints. A drug that extends survival but destroys quality of life isn't a clear win.
The editorial process is thorough but efficient
Expect detailed statistical review. NEJM employs dedicated statisticians who will scrutinize your analysis plan and execution.
Negative trials can be published if well-designed
NEJM values well-conducted trials that definitively show a treatment doesn't work. These change practice too. They prevent use of ineffective therapies.
The NEJM Submission Process
Presubmission inquiry (rarely needed)
Response within 1 week if submittedNEJM prefers full submissions. Inquiries mainly useful for highly unusual study types.
Full submission
Decision within 21 daysComplete manuscript with structured abstract, trial registration, CONSORT checklist (for trials), data sharing statement.
Editorial review
~10 daysRapid triage by editors. High desk rejection rate (~80%). Focus on clinical significance and impact.
Statistical review
Concurrent with editorial reviewPapers advancing to peer review undergo preliminary statistical assessment.
Peer review
3-4 weeksClinical experts and methodologists. Emphasis on validity, clinical relevance, and practice impact.
Decision
21 days median to first decisionAccept, reject, or revise. Revision requests typically focused and achievable.
NEJM by the Numbers
| 2024 Impact Factor(Clarivate JCR, 2nd in Medicine, General & Internal) | 78.5 |
| Submissions per year | ~5,000 Original Articles |
| Acceptance rate | <5% |
| Desk rejection rate | ~80% |
| Post-review acceptance | ~25% of reviewed |
| Median to first decision | 21 days |
| Weekly publication | 52 issues/year |
| Readership | 600,000+ physicians worldwide |
Before you submit
NEJM accepts a small fraction of submissions. Make your attempt count.
Start with the Free Readiness Scan. Unlock the Full AI Diagnostic for $29. If you need deeper scientific feedback, choose Expert Review. The full report is calibrated to NEJM.
Article Types
Original Article
2,700 words, 4-5 tables/figuresFull reports of clinical research, typically randomized trials
Special Article
VariableImportant topics that don't fit standard research format
Brief Report
1,200 wordsConcise reports of important findings
Case Records of MGH
Case-based formatClinical problem-solving cases (by invitation)
Landmark NEJM Papers
Papers that defined fields and changed science:
- First use of ether anesthesia (1846)
- SPRINT trial: intensive vs. standard blood-pressure control (2015)
- Framingham Heart Study foundational papers (1961-)
- Imatinib (Gleevec) for chronic myeloid leukemia - Druker et al. (2001)
- Efficacy of COVID-19 vaccines (2020)
Preparing a NEJM Submission?
Get pre-submission feedback from reviewers who've published in NEJM and know exactly what editors look for.
Run Free Readiness ScanNeed expert depth? See Expert Review Options
Primary Fields
Browse by Field
Related Journal Guides
- Publishing in The Lancet
- Publishing in JAMA (Journal of the American Medical Association)
- Publishing in The BMJ (British Medical Journal)
- Publishing in Circulation
- Publishing in European Heart Journal
Latest Journal-Specific Guides
- Submission guideNEJM Submission GuideA practical NEJM submission guide for authors deciding whether the manuscript has the clinical consequence, breadth, and package quality NEJM expects.
- Journal assessmentIs New England Journal of Medicine a Good Journal? A Practical Fit VerdictA practical NEJM fit verdict for authors deciding whether their study is truly practice-changing enough for one of medicine's hardest editorial screens.
- Desk rejectionHow to Avoid Desk Rejection at NEJMHow to avoid desk rejection at NEJM: prove broad clinical consequence, hard endpoints, and study authority strong enough for general medicine.
- Review timelineNew England Journal of Medicine Review Time: Time to First Decision and PublicationNEJM has one of the fastest turnaround times in academic medicine: most papers get a first decision within 1-3 weeks. That speed reflects a very high desk rejection rate. Here's the complete timeline.
More Guides for This Journal
- Acceptance rateNEJM Acceptance Rate 2026: What the Numbers MeanNEJM accepts 5-6% of manuscripts and desk-rejects over 90%. The numbers matter, but the more useful question is whether your paper is broad and practice-changing enough to clear the desk.
- Impact factorNew England Journal of Medicine Impact Factor 2026: 78.5, Q1, Rank 2/332NEJM impact factor is 78.5 (JCR 2024). Q1, rank 2/332 in General Medicine. h-index 1493. See the trend, how it compares, and what it takes to publish here.
- Submission processNEJM Submission Process: Steps & TimelineA practical NEJM submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
- Manuscript prepHow to Write a NEJM Cover Letter (With Template)NEJM desk-rejects more than 80% of submissions, often within 7 days. The cover letter is your first and sometimes only chance to make the case for why your paper belongs there.
- Publishing guideNew England Journal of Medicine Formatting Requirements: The Practical Package GuideNEJM formatting is not just word count. This guide covers the manuscript package, reporting documents, and compliance details that can delay or weaken a submission.
中文版本
阅读中文投稿指南 →Ready to submit to NEJM?
A desk rejection costs months. Get expert feedback before you submit, from scientists who know exactly what NEJM editors look for.
Avoid Desk Rejection
Get expert pre-submission review before you submit to NEJM. 3-7 day turnaround.
Manuscript Rejected?
Expert revision help to strengthen your manuscript and resubmit with confidence.
Reviewer Response Help
Get expert guidance crafting your response to NEJM reviewers.
Reference library
Compare NEJM with the broader publishing context
This journal guide is the best starting point for NEJM. The reference library covers the surrounding questions authors usually ask next: whether the package is ready, what drives desk rejection, how neighboring journals compare, and what the submission constraints look like across the field.
Checklist system / operational asset
Elite Submission Checklist
A flagship pre-submission checklist that turns journal-fit, desk-reject, and package-quality lessons into one operational final-pass audit.
Flagship report / decision support
Desk Rejection Report
A canonical desk-rejection report that organizes the most common editorial failure modes, what they look like, and how to prevent them.
Dataset / reference hub
Journal Intelligence Dataset
A canonical journal dataset that combines selectivity posture, review timing, submission requirements, and Manusights fit signals in one citeable reference asset.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Need field-expert depth? See Expert Review Options